Drug Law Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Law Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Alzheimer Disease
Scientific Founder of TorreyPines Therapeutics Honored by Alzheimer's Association
April 10th, 2007
Rudy Tanzi, Ph.D., a scientific founder of TorreyPines Therapeutics, Inc. (NASDAQ:TPTX) and an important contributor to the TorreyPines' genetic research program in Alzheimer's disease has been selected by the Alzheimer's Association as the 2007 recipient of the Ronald and Nancy Reagan Research Institute Award, given annually for outstanding research in the field of Alzheimer's disease. He will be honored along with other leaders in the fight against Alzheimer's disease, including Senators Hillary Rodham Clinton and Susan Collins and Princess Yasmin Aga Khan, at the Alzheimer's Association's annual gala on March 27 in Washington, D.C. Dr. Tanzi's career in neurogenetic...
Source: Drug Law Weekly (2007-04-10)
|
